Celu­lar­i­ty teams up with Aus­tralian biotech to de­vel­op CAR T-cell ther­a­py; For­mer Kin­nate CEO Stephen Kaldor reels in $50M for new biotech

Imu­gene and Celu­lar­i­ty have an­nounced a part­ner­ship to de­vel­op a sol­id tu­mor treat­ment, the two com­pa­nies an­nounced Wednes­day.

The col­lab­o­ra­tion will ex­plore the use of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER